Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: results of a multicenter phase II study. (Q45992466)
Jump to navigation
Jump to search
scientific article published on 23 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: results of a multicenter phase II study. |
scientific article published on 23 May 2009 |
Statements
1 reference
Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: results of a multicenter phase II study. (English)
1 reference
D S McMeekin
1 reference
A Lisyanskaya
1 reference
M Crispens
1 reference
A M Oza
1 reference
D Doering
1 reference
E Bayever
1 reference
B Michiels
1 reference
M Markman
1 reference
23 May 2009
1 reference
1 reference
114
1 reference
2
1 reference
288-292
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
2 references
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference